ADC Therapeutics (ADCT) Other Non Operating Income (2019 - 2023)
Historic Other Non Operating Income for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to $860000.0.
- ADC Therapeutics' Other Non Operating Income rose 10231.67% to $860000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was -$4.2 million, marking a year-over-year increase of 6096.72%. This contributed to the annual value of -$604.0 million for FY2022, which is 212021653.62% down from last year.
- ADC Therapeutics' Other Non Operating Income amounted to $860000.0 in Q3 2023, which was up 10231.67% from -$5.1 million recorded in Q2 2023.
- In the past 5 years, ADC Therapeutics' Other Non Operating Income ranged from a high of $13.4 million in Q1 2022 and a low of -$37.1 million during Q3 2022
- Over the past 5 years, ADC Therapeutics' median Other Non Operating Income value was -$230.0 (recorded in 2019), while the average stood at -$1.5 million.
- Per our database at Business Quant, ADC Therapeutics' Other Non Operating Income plummeted by 655724.14% in 2021 and then soared by 367277759.56% in 2022.
- Over the past 5 years, ADC Therapeutics' Other Non Operating Income (Quarter) stood at $222.0 in 2019, then skyrocketed by 65215.32% to $145000.0 in 2020, then tumbled by 89.01% to $15929.0 in 2021, then tumbled by 108.0% to -$1275.0 in 2022, then skyrocketed by 67550.98% to $860000.0 in 2023.
- Its last three reported values are $860000.0 in Q3 2023, -$5.1 million for Q2 2023, and -$3000.0 during Q1 2023.